Report Detail

This report focuses on the global Sexually Transmitted Diseases (STD) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sexually Transmitted Diseases (STD) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
ROCHE HOLDINGS
BIOMERIEUX
HOLOGIC
BECTON DICKINSON
ORASURE
DANAHER
AFFYMETRIX
ABBOTT LABORATORIES
BIO-RAD LABORATORIES
DIASORIN

Market segment by Type, the product can be split into
Chlamydia
Syphilis
Gonorrhea
Herpes Simplex Virus
Human Papilloma Virus
Human Immunodeficiency Virus
Others
Market segment by Application, split into
Laboratory Testing
Point of Care (POC) Testing

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Sexually Transmitted Diseases (STD) Testing status, future forecast, growth opportunity, key market and key players.
To present the Sexually Transmitted Diseases (STD) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Sexually Transmitted Diseases (STD) Testing are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Sexually Transmitted Diseases (STD) Testing Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Chlamydia
    • 1.4.3 Syphilis
    • 1.4.4 Gonorrhea
    • 1.4.5 Herpes Simplex Virus
    • 1.4.6 Human Papilloma Virus
    • 1.4.7 Human Immunodeficiency Virus
    • 1.4.8 Others
  • 1.5 Market by Application
    • 1.5.1 Global Sexually Transmitted Diseases (STD) Testing Market Share by Application: 2020 VS 2026
    • 1.5.2 Laboratory Testing
    • 1.5.3 Point of Care (POC) Testing
  • 1.6 Coronavirus Disease 2019 (Covid-19): Sexually Transmitted Diseases (STD) Testing Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Sexually Transmitted Diseases (STD) Testing Industry
      • 1.6.1.1 Sexually Transmitted Diseases (STD) Testing Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Sexually Transmitted Diseases (STD) Testing Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Sexually Transmitted Diseases (STD) Testing Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Sexually Transmitted Diseases (STD) Testing Market Perspective (2015-2026)
  • 2.2 Sexually Transmitted Diseases (STD) Testing Growth Trends by Regions
    • 2.2.1 Sexually Transmitted Diseases (STD) Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Sexually Transmitted Diseases (STD) Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Sexually Transmitted Diseases (STD) Testing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Sexually Transmitted Diseases (STD) Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Sexually Transmitted Diseases (STD) Testing Players by Market Size
    • 3.1.1 Global Top Sexually Transmitted Diseases (STD) Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Sexually Transmitted Diseases (STD) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio
    • 3.2.1 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases (STD) Testing Revenue in 2019
  • 3.3 Sexually Transmitted Diseases (STD) Testing Key Players Head office and Area Served
  • 3.4 Key Players Sexually Transmitted Diseases (STD) Testing Product Solution and Service
  • 3.5 Date of Enter into Sexually Transmitted Diseases (STD) Testing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Type (2021-2026)

5 Sexually Transmitted Diseases (STD) Testing Breakdown Data by Application (2015-2026)

  • 5.1 Global Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)
  • 5.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
  • 6.2 Sexually Transmitted Diseases (STD) Testing Key Players in North America (2019-2020)
  • 6.3 North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
  • 6.4 North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
  • 7.2 Sexually Transmitted Diseases (STD) Testing Key Players in Europe (2019-2020)
  • 7.3 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
  • 7.4 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)

8 China

  • 8.1 China Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
  • 8.2 Sexually Transmitted Diseases (STD) Testing Key Players in China (2019-2020)
  • 8.3 China Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
  • 8.4 China Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
  • 9.2 Sexually Transmitted Diseases (STD) Testing Key Players in Japan (2019-2020)
  • 9.3 Japan Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
  • 9.4 Japan Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
  • 10.2 Sexually Transmitted Diseases (STD) Testing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)

11 India

  • 11.1 India Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
  • 11.2 Sexually Transmitted Diseases (STD) Testing Key Players in India (2019-2020)
  • 11.3 India Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
  • 11.4 India Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
  • 12.2 Sexually Transmitted Diseases (STD) Testing Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
  • 12.4 Central & South America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 ROCHE HOLDINGS
    • 13.1.1 ROCHE HOLDINGS Company Details
    • 13.1.2 ROCHE HOLDINGS Business Overview and Its Total Revenue
    • 13.1.3 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Introduction
    • 13.1.4 ROCHE HOLDINGS Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020))
    • 13.1.5 ROCHE HOLDINGS Recent Development
  • 13.2 BIOMERIEUX
    • 13.2.1 BIOMERIEUX Company Details
    • 13.2.2 BIOMERIEUX Business Overview and Its Total Revenue
    • 13.2.3 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Introduction
    • 13.2.4 BIOMERIEUX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
    • 13.2.5 BIOMERIEUX Recent Development
  • 13.3 HOLOGIC
    • 13.3.1 HOLOGIC Company Details
    • 13.3.2 HOLOGIC Business Overview and Its Total Revenue
    • 13.3.3 HOLOGIC Sexually Transmitted Diseases (STD) Testing Introduction
    • 13.3.4 HOLOGIC Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
    • 13.3.5 HOLOGIC Recent Development
  • 13.4 BECTON DICKINSON
    • 13.4.1 BECTON DICKINSON Company Details
    • 13.4.2 BECTON DICKINSON Business Overview and Its Total Revenue
    • 13.4.3 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Introduction
    • 13.4.4 BECTON DICKINSON Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
    • 13.4.5 BECTON DICKINSON Recent Development
  • 13.5 ORASURE
    • 13.5.1 ORASURE Company Details
    • 13.5.2 ORASURE Business Overview and Its Total Revenue
    • 13.5.3 ORASURE Sexually Transmitted Diseases (STD) Testing Introduction
    • 13.5.4 ORASURE Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
    • 13.5.5 ORASURE Recent Development
  • 13.6 DANAHER
    • 13.6.1 DANAHER Company Details
    • 13.6.2 DANAHER Business Overview and Its Total Revenue
    • 13.6.3 DANAHER Sexually Transmitted Diseases (STD) Testing Introduction
    • 13.6.4 DANAHER Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
    • 13.6.5 DANAHER Recent Development
  • 13.7 AFFYMETRIX
    • 13.7.1 AFFYMETRIX Company Details
    • 13.7.2 AFFYMETRIX Business Overview and Its Total Revenue
    • 13.7.3 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Introduction
    • 13.7.4 AFFYMETRIX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
    • 13.7.5 AFFYMETRIX Recent Development
  • 13.8 ABBOTT LABORATORIES
    • 13.8.1 ABBOTT LABORATORIES Company Details
    • 13.8.2 ABBOTT LABORATORIES Business Overview and Its Total Revenue
    • 13.8.3 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
    • 13.8.4 ABBOTT LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
    • 13.8.5 ABBOTT LABORATORIES Recent Development
  • 13.9 BIO-RAD LABORATORIES
    • 13.9.1 BIO-RAD LABORATORIES Company Details
    • 13.9.2 BIO-RAD LABORATORIES Business Overview and Its Total Revenue
    • 13.9.3 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
    • 13.9.4 BIO-RAD LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
    • 13.9.5 BIO-RAD LABORATORIES Recent Development
  • 13.10 DIASORIN
    • 13.10.1 DIASORIN Company Details
    • 13.10.2 DIASORIN Business Overview and Its Total Revenue
    • 13.10.3 DIASORIN Sexually Transmitted Diseases (STD) Testing Introduction
    • 13.10.4 DIASORIN Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
    • 13.10.5 DIASORIN Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Sexually Transmitted Diseases (STD) Testing. Industry analysis & Market Report on COVID-19 Impact on Global Sexually Transmitted Diseases (STD) Testing is a syndicated market report, published as COVID-19 Impact on Global Sexually Transmitted Diseases (STD) Testing Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Sexually Transmitted Diseases (STD) Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,014.70
    4,522.05
    6,029.40
    3,630.90
    5,446.35
    7,261.80
    595,491.00
    893,236.50
    1,190,982.00
    329,160.00
    493,740.00
    658,320.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report